REBECCA LOUISE DAVIE,HANNAH JOY EDWARDS,DAVID MICHAEL EVANS,SIMON TEANBY HODGSON
申请号：
PT15804210
公开号：
PT3224256T
申请日:
2015.11.26
申请国别(地区):
PT
年份:
2019
代理人:
摘要：
The present invention provides compounds of formula (I):compositions comprising such compounds； the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated)； and methods of treating patients with such compounds； wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein.
